Phathom Insider Buy Signals Value: 8,750 Shares at 34% Discount – What Investors Must Know
Phathom Pharmaceuticals insider buy: 8,750 shares at $10.30—below $15.14—signals long‑term confidence in GI therapeutics and a potential value play amid low P/E, regulatory hurdles.
4 minutes to read